Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP967765.RAYzEP6POtlkHMjZ_EG6UQLUYO-M4H1x2Ya2h4-fCVHTc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP967765.RAYzEP6POtlkHMjZ_EG6UQLUYO-M4H1x2Ya2h4-fCVHTc130_assertion type Assertion NP967765.RAYzEP6POtlkHMjZ_EG6UQLUYO-M4H1x2Ya2h4-fCVHTc130_head.
- NP967765.RAYzEP6POtlkHMjZ_EG6UQLUYO-M4H1x2Ya2h4-fCVHTc130_assertion description "[Fifty-nine squamous cell carcinomas (SCC) and 43 adenocarcinomas (AD) were immunohistochemically examined for respective EMT markers and for EGFR, using the EGFR PharmDx kit (Dako) for protein expression and automated silver enhanced in situ hybridization (SISH) for copy number.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967765.RAYzEP6POtlkHMjZ_EG6UQLUYO-M4H1x2Ya2h4-fCVHTc130_provenance.
- NP967765.RAYzEP6POtlkHMjZ_EG6UQLUYO-M4H1x2Ya2h4-fCVHTc130_assertion evidence source_evidence_literature NP967765.RAYzEP6POtlkHMjZ_EG6UQLUYO-M4H1x2Ya2h4-fCVHTc130_provenance.
- NP967765.RAYzEP6POtlkHMjZ_EG6UQLUYO-M4H1x2Ya2h4-fCVHTc130_assertion SIO_000772 22419022 NP967765.RAYzEP6POtlkHMjZ_EG6UQLUYO-M4H1x2Ya2h4-fCVHTc130_provenance.
- NP967765.RAYzEP6POtlkHMjZ_EG6UQLUYO-M4H1x2Ya2h4-fCVHTc130_assertion wasDerivedFrom befree-2016 NP967765.RAYzEP6POtlkHMjZ_EG6UQLUYO-M4H1x2Ya2h4-fCVHTc130_provenance.
- NP967765.RAYzEP6POtlkHMjZ_EG6UQLUYO-M4H1x2Ya2h4-fCVHTc130_assertion wasGeneratedBy ECO_0000203 NP967765.RAYzEP6POtlkHMjZ_EG6UQLUYO-M4H1x2Ya2h4-fCVHTc130_provenance.